Mnemo Therapeutics specializes in biotechnology and life science. Founded by 0 in 2019, Mnemo Therapeutics is backed by investors that include Casdin Capital, Alexandria Venture Investments, Emerson Collective, Redmile Group, and Sofinnova Partners and is headquartered in Paris.